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P-domainCalreticulin (CRT) is an important chaperone protein, comprising an N-domain, P-domain and C-domain. It is
involved in the folding and assembly of multi-component protein complexes in the endoplasmic reticulum,
and plays a critical role in MHC class I antigen processing and presentation. To dissect the functional role and
molecular basis of individual domains of the protein, we have utilized individual domains to rescue impaired
protein assembly in a CRT deﬁcient cell line. Unexpectedly, both P-domain fragment and NP domain of CRT
not only failed to rescue defective cell surface expression of MHC class I molecules but further inhibited their
appearance on the surface of cells. Formation of the TAP-associated peptide-loading complex and trafﬁcking
of the few detectable MHC class I molecules were not signiﬁcantly impaired. Instead, this further suppression
of MHC class I molecules on the cell surface appears due to the complex missing antigenic peptides, the third
member of fully assembled MHC class I molecules. Therefore the P-domain of calreticulin appears to play a
signiﬁcant role in antigen presentation by MHC class I molecules.reticulum; TAP, transporter
roglobulin; OVA, ovalbumin;
District, Beijing 100101, China.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Peptide loading onto MHC class I heavy chain (HC)-β2-micro-
globulin (β2M) heterodimers is critical for both the structural stability
and the function of MHC class I molecules and is assisted by the
peptide-loading complex (PLC) [1]. Calreticulin (CRT) is an important
member of the PLC and plays a central role in the formation of the PLC
by interacting with other component of the complex. As a molecular
chaperone in the endoplasmic reticulum (ER), CRT interacts with
newly synthesized glycoproteins that have undergone partial trim-
ming of their core N-linked oligosaccharides. Together with the
enzymes responsible for glucose removal and a glucosyltransferase
that re-glucosylates already-trimmed glycoproteins, they provide a
novel mechanism for promoting folding, oligomeric assembly and
quality control in the ER [2]. CRT associates with MHC class I after its
heavy chain is assembled with β2M [3–6]. The association of CRT with
MHC I is not dependent on either TAP or tapasin, but appears to be a
prerequisite for the association of class I with TAP via tapasin.Disrupting the CRT interaction with class I HC by either mutation of
the Asn-linked glycosylation site at position 86 [3,6,7], or by using the
drug castanospermine to block the action of glucosidase I and II to
prevent the generation of themonoglucosyl-glycan recognised by CRT
[4,8] has been demonstrated. Furthermore, fewer class I molecules
were incorporated into the PLC in the absence of CRT [9]. In addition to
its association with class I HC, CRT has been found to interact with
ERp57 through the tip of its P-domain [10,11]. It was suggested that
CRT recruits ERp57, providing an “attachment” site for this enzyme to
mediate disulﬁde bond formation in newly synthesized glycoproteins.
In this context, ERp57 chaperone activity is greatly increased when
complexed with CRT [12].
Functionally, CRT has been suggested to stabilize and retain the
HC-β2M heterodimer in the ER until the antigenic peptide is loaded.
Studies have shown that CRT preferentially binds to open conforma-
tions of MHC class I [3,4] and does not associate with the class I after
peptide-induced folding [3]. Furthermore, CRT deﬁcient cells have
reduced cell surface class I expression and fail to present the majority
of epitopes tested to speciﬁc T cells, which suggests that CRT is critical
for MHC class I assembly and its subsequent antigen presentation [9].
We have also shown that higher concentration of antigen in the
cytosol is required for speciﬁc T cell stimulation in CRT deﬁcient cells
than in CRT competent cells, whereas TAP function and protein
expression level was the same [13]. Recent report [14] suggests that
calreticulin recycles the sub-optimally loaded class I from the Golgi to
545C. Liu et al. / Biochimica et Biophysica Acta 1803 (2010) 544–552the ER for loading, and the phenotype might contribute to maintain a
low peptide concentration threshold required for efﬁcient antigen
presentation [13].
To learn more about how CRT contributes to MHC class I antigen
presentation and how the function of CRT relates to its structure, full
length CRT or one of the three structurally and functionally distinct
domains; the N-domain, the central P-domain, and the C-domain,
were introduced into CRT deﬁcient cells (K42) to examine the role of
CRT and its truncated forms in the formation of the peptide loading
complex and MHC class I antigen presentation. An assessment was
also made on the effect of such expression on different steps involved
in antigen processing, such as peptide loading, TAP function, and
expression of other members of the PLC.
2. Results
2.1. Loss of class I surface expression in CRT deﬁcient cells by transfection
of truncated CRT
To further dissect the role of calreticulin in MHC class I antigen
processing, different domains of CRT (Fig. 1a) were ampliﬁed and
cloned into the vector pEF/myc/ER (Invitrogen, UK) containing a
leader signal and an ER retention sequence to make sure that all
fragments has similar ER location in the cell. A set of stable cell linesFig. 1. ER-targeted expression of CRT and its fragments in both K42 (CRT−/−) and K41 (CR
280), PC (AA180–400), P (AA180–280) fragments used in this study. Individual fragments an
leader signal and a myc tag plus SEKDEL ER retention signal in vector pEF/myc/ER. (b) TheW
constructs were transfected onto both K42 and K41 cell lines. The stable cell lines were selec
Triton X-100, and proteins were separated by 12.5% SDS-PAGE, transferred to Hybond Extra
mAb conﬁrms transfection of P, PC, NP and full length CRT into K42 (top) and K41 (bottom) c
cells were transfected with the pEF/myc/ER vectors encoding ER-targeted full length CRT (n
selection and limited dilution cloning. The localisation of all fragments in the cells was an
pattern characteristic of ER. The experiments were repeated at least three times with simil(both K41 and K42) expressing the full-length human CRT or its P, PC
and NP domains were established by G418 selection and limited
dilution cloning. The expression of myc tagged proteins in established
cell lines was conﬁrmed by western blot using anti-myc tag antibody.
As shown in Fig. 1b the anti-myc antibody reacted with a 60 kDa
protein in CRT transfected K42 cells, and a 30 kDa protein in P domain
transfectants, and with a 45 kDa protein in PC and NP transfectants.
All truncated fragments fused with ER retention signal were seen to
stay in the ER (Fig. 1c) and co-localized with calnexin, an ER resident
protein.
To ﬁnd out whether any of these transfectants might restore the
reduced class I surface expression in calreticulin deﬁcient cell line
K42 (CRT−/−), mouse class I (H-2Kb) on transfected cells was
detected with Y3, a H-2Kb conformation dependent monoclonal
antibody. To our surprise although the full length CRT restored the
surface MHC class I expression in CRT deﬁcient K42 as expected, the
introduction of P, PC, and NP fragments into the cells not only failed
to rescue the lower surface expression caused by calreticulin deﬁ-
ciency, but further suppressed MHC class I surface expression on
such cell lines (Fig. 2a). Among them P-domain of calreticulin almost
completely abolished class I surface expression. These results might
indicate that the individual fragments had a major impact on class I
synthesis and folding, or caused some other damage to the
transfected cells, which leads to down-regulation of surface class IT+/+) cells. (a) Schematic representation of full length calreticulin and its NP (AA1–
d full length CRT omitting original ER retention signal were cloned into between the ER
estern blot analysis of recombinant CRT and its P, PC and NP fragments. The individual
ted with G418 and cloned by limited dilution. The established cell lines were lysed in 1%
membrane (Amersham), and probed with anti-myc mAb. Western blot with anti-myc
ells. (c) Intracellular ER distribution of recombinant CRT and its fragments. K42 and K41
ot for K41 cells) and its P, PC, NP fragments. The stable cell lines were obtained by G418
alysed by immunoﬂuorescence microscopy (100×), revealing a reticular, perinuclear
ar results and representative result was shown.
Fig. 2. Down-regulation of MHC class I by truncated CRT in the absence of calreticulin. (a) Cell-surface expression of murine MHC class I Kb on K42, K41 cells and their transfectants
were detected by ﬂow cytometry using monoclonal antibody anti H-2Kb (Y3). Left panel: the MHC class I on K42-P, K42-PC and K42-NP cells (thick line) are down-regulated
compared with that on K42 cells, while full length human CRT restored MHC class I surface expression to the same level seen in wild-type cells (K41). Right panel: all K41
transfectants showed the same surface expression level of MHC class I (thick line) as that of K41. Shaded areas indicate second antibody only. (b) Similar levels of CRT fragments
were expressed between K41 and K42 cell lines. 1×106 of individual cells were double diluted and lysed on ice in 1 ml Tris buffered saline (TBS, pH 7.4) containing 0.5% Nonidet P-
40, 0.5 mM PMSF (Sigma) and 2 mg/ml IAA (Sigma). The lysates in the supernatant were run on 10% SDS-PAGE and blotted with anti-myc and anti-calnexin antibodies as loading
control. The experiments were repeated at least three times with similar results and representative result was shown.
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for K42 cell were transfected into K41 (CRT+/+) cells, the surface
class I expression in all these transfectants was found at the same level
as that of parental K41 cells (Fig. 2a). Onemay argue that the difference
of MHC class I expression between CRT positive and negative cell lines
is due to different expression levels of CRT fragments. To clarify this we
analyse the amount of individual CRT fragments expressed in both cell
lines. The results shown in Fig. 2b demonstrate that there is almost
equal amount of CRT fragments expressed in both CRT competent and
deﬁcient cell lines. Down-regulatedMHC class I expression caused by P-
domain only happens in the absence of CRT.
2.2. Signiﬁcant reduction of class I molecule in CRT domain transfected
cells while other components associated with class I assembly remains
unchanged
One of the important functions of CRT is quality control for the
protein trafﬁcking and folding. Without proper involvement ofFig. 3. Chaperone proteins in truncated CRT transfected K42 cells are unchanged. (a) The rel
cell lysates for each cell line were subjected to 12% SDS-PAGE and transferred onto Hybond E
heavy chain, ERp57 and TAP. The results shown are representative of those obtained in three
with Software Quantity One 4.6.2 (Bio-RAD). The plots with normalization against CNX, (wh
shown in right panel. (b) The treatment of cells with proteasome inhibitors was used to anal
MG-115 (Alexis, USA) and MG-132 (Alexis, USA) diluted in DMSO were added to cell culture
the same amount of DMSO. Treated cells were collected and lysed on ice in 1 ml Tris buffe
proteinase inhibitors. The lysates were resolved by 15% SDS-PAGE and analysed by immun
representative result was shown.chaperones the membrane bound or secreted proteins may not fold
or assemble efﬁciently, and subsequently these misfolded or mis-
assembled proteins would undergo ER-associated protein degrada-
tion [15–18]. We therefore determined if components of the MHC
class I loading complex, such as calnexin, tapasin, HC and ERp57, are
affected in calreticulin domain transfected cell lines, potentially af-
fecting the folding and assembly of MHC class I molecules. We used
semi-quantitative western blotting to test whether the expression of
these components are affected, or failed to form the peptide loading
complex. Two-fold dilutions of cell lysates, prepared in the presence
of a cocktail of proteinase inhibitors, were separated by standard
SDS-PAGE. The levels of calnexin, tapasin, HC and ERp57 from K42
(CRT−/−) cells transfected with truncated CRTs and the parent cell
line K42 (CRT−/−) were probed with appropriate antibodies in
western blot. The results shown in Fig. 3a indicate that the steady
state expression of calnexin, tapasin and ERp57 were all similar for
K42-P, K42-PC, K42-NP and K42 cells. (left panel). It is clearer when
we normalize the expression against an internal standard, calnexinative amount of ER chaperons was analysed by western blot. Two fold serial dilutions of
xtra membrane (Amersham), and probed with speciﬁc antibodies for calnexin, tapasin,
separate experiments (left panel). The blots were scanned and analysed quantitatively
ere CNX was not available Tpn was used) for individual CRT domain transfectants were
yse whether HC steady state levels can be rescued in transfectant cell lines. A mixture of
s both at a ﬁnal concentration of 5 μM for 6 h, whereas control plates were treated with
red saline (TBS, pH 7.4) containing 0.5% Nonidet P-40 in the presence of a cocktail of
oblotting. All experiments were repeated at least three times with similar results and
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associated with MHC class I antigen processing expressed between
K42 or K42 transfectedwith CRT fragments appeared the same. There
appeared some difference for TAP2 expression between K42 and
CRT-P domain transfected K42 on the blot (left panel). But when
TAP2 expression is normalized against tapasin the expression level
appeared the same, indicating TAP2 expression remains the same in
K42 transfected with CRT-P domain. Finally, the overall protein
expression level of HC in truncated CRT transfected K42 cells was
lower than that of parent K42 cells. However, the decreased MHC
class I molecule in CRT-P domain transfected cells seems not to rely
on proteasome function since there is no difference for HC expression
between cells with or without proteasome inhibitors (Fig. 3b).
2.3. Normal TAP function in transfected cell lines
Peptide supply to the ER can regulate cell surface expression of
MHC class I. Virally induced inhibition of TAP function down-regulates
class I surface expression [19,20], while increased TAP levels can
enhance its expression on the cell surface [20]. It is possible that the
empty or sub-optimally loaded class I molecules in K42-P, K42-PC and
K42-NP cells were caused by shortage of peptide supply in the ER due
to the dysfunction of TAP either structurally or functionally. Without
the support of other domains, individual CRT fragments might not
perform their chaperone function properly, leading to misfolded or
misassembled proteins, which are eventually targeted for degradation
[15–18]. Such individual CRT domains might affect the expression or
function of TAP directly or indirectly e.g. by modiﬁcation of the envi-
ronment in the ER. Although the expression of TAP seems unaffected
in these cell lines, this does not prove that TAP function is maintained.
To clarify this, a peptide transport assay was carried out to compare
TAP function in K42-P, K42-PC and K42-NP with that of parental K42
(CRT−/−) cells. Cells were permeabilized with streptolysin O, then
incubated with FITC labelled peptide RRYQNSTEL containing an N-
linked glycosylation motif. In the presence of functional TAP, the
peptide was translocated into the ER, where it is glycosylated and can
be recovered by binding to concanavalin A-Sepharose beads [21]. The
ﬂuorescence intensity of eluted peptide from concanavalin A beads
were quantitatively analysed by ﬂuorescence spectrometer. As shown
in Fig. 4, an equal amount of FITC labelled peptides were transportedFig. 4. TAP function is normal in truncated CRT transfected K42 cells. Cells were
permeabilized by incubation with slo as described in Materials and methods. FITC-
labelled peptides with a glycosylation site (RRYQNSTEL) were incubated with
permeabilized and entered the cells. The peptides were subsequently transported by
TAP from cytosol into the lumen of ER, where the peptides were glycosylated. Cells
were then lysed, and glycosylated peptides bound to Con-A beads were eluted. The
ﬂorescent intensity of FITC labelled RRYQNSTEL was quantiﬁed using a ﬂuorescence
spectrometer as described in Materials and methods. Data are presented as the
percentage of transported peptides and shown as means SD of three independent
experiments.into the ER for all the truncated CRT K42 transfectants and K42 cells.
This suggests that the ability of TAP to carry out the function of
translocating peptide from cytosol into the ER remains unchanged,
which is consistent with the normal synthesis of TAP in K42-P, K42-PC
and K42-NP cells. In the ﬁgure, RMA, a mouse tumour cell line with H-
2b background was used as positive control while its TAP deﬁcient
counterpart, RMA-S was used as negative control.
2.4. The trafﬁcking of class I molecules and its association with peptide
loading complex are unchanged in P-domain transfected calreticulin
deﬁcient cells
In certain circumstances, class I molecules are not maintained in
the ER for a sufﬁcient time to enable them to properly load with
optimised peptides. They often travel to the surface of the cell faster
and are degraded. For example, in a tapasin deﬁcient cells, the
association of class I MHC molecules with TAP is disrupted and ER
retention of class I molecules is also lost [22]. If this were the case we
would expect a fast trafﬁcking speed of class I molecules in calreticulin
domain transfected cells. Pulse-chase experiments using P-domain
transfected cells and its parent cells were carried out to determine
whether transport rate of class I molecules was altered in calreticulin
P-domain transfected cells. However, the results shown in Fig. 5bFig. 5. Assembly of peptide-loading complex in K42, K41 and their CRT P-domain
transfectants, and transport of folded molecules to the cell surface. (a) Cell lysates (left
panel), and immunoprecipitates of TAP and associated proteins (right panel), were
made from K41, K41-P, K42 and K42-P, fractioned by SDS-PAGE, and probed for tapasin,
ERp57, TAP, CRT and MHC class I HC. (b) K42 and K42-P cells were pulse labelled and
cells were removed at the indicated timepoints, followed by detergent lysis,
immunoprecipitation of Kb, and digestion with endo H. The experiments were
repeated at least twice with similar results and representative result was shown.
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domain transfected cells is similar to that in its parent calreticulin
negative cells, although fewer class I moleculeswere precipitated in P-
domain transfected cells. Previouswork fromGao et al. showed that in
the absence of CRT (K42), MHC class I was still incorporated into the
PLC, but at reduced levels [9]. Whether truncated CRT affect compo-
sition of PLC or the incorporation of class I molecules into the loading
complex in the absence of calreticulin remained undetermined. Thus
co-immunoprecipitation experiments combined with western blot
analysis were carried out using K42-P cell paired with parental K42
cells to investigate the formation of the PLC in these cell lines. Anti-
TAP antibody precipitates from digitonin extracts of the cell lineswere
probedwith antibodies to tapasin, ERp57, TAP, CRT, calnexin andMHC
class I HC. As shown in Fig. 5a similar quantities of tapasin, ERp57 and
TAP were present in the TAP precipitates. As expected, CRT can be
detected in both K41 cell and its CRT P-domain transfectant, but it is
absent in K42 and its CRT P-domain transfectants. Similar level of class
I detected in PLC of K42-P and K42 cells. Compared to the K41 series
cells, densitometric analysis indicated that approximately 75% fewer
MHC class I molecules were TAP associated in the K42 series cells.
Overall, the results indicated that the presence of CRT P-domain did
not signiﬁcantly inﬂuence the formation of the PLC in either CRT
deﬁcient (K42) or competent cells (K41).
2.5. Abolition of endogenous antigen presentation to T cells in CRT
fragment transfected cell lines
Cells demonstrating reduced surface expression of class I mole-
cules are still able to process endogenous antigen and present speciﬁc
epitopes to T cells, although at reduced efﬁciency, such as in the cases
of tapasin, ERp57 and calreticulin deﬁcient cells. However, the level of
down-regulation of surface expression in these knockout cells is much
less compared to that which we see in calreticulin-domain tranfected
K42 cells, in which the surface expression of MHC class I was almost
abolished. To determine the effect of truncated forms of CRT in K42
(CRT−/−) cells on antigen processing and presentation, their ability
to process endogenous ovalbumin epitope SIINFEKL to the T cell
hybridoma B3Z [23,24] was assessed. OVA protein was delivered into
cells by incubation of the protein with cells treated with SLO [25]. As
shown in Fig. 6, the ability of K42 (CRT−/−) cells transfected with P-
domain andNP-domain to process endogenous antigen and present to
speciﬁc T cells is abolished, while PC domain also signiﬁcantly inhibitsFig. 6. MHC class I endogenous antigen presentation in calreticulin domain
transfectants. Streptolysin O permeabilized cells were incubated with different
concentrations of ovalbumin, and then co-cultured with the lacZ-inducible, SIIN-
FEKL/Kb-speciﬁc B3Z T cell hybridoma overnight. The colour intensity as indication of
B3Z activation was evaluated by an ELISA reader as described inMaterials andmethods.
Experiment was carried out in triplicate each time and repeated at least three times for
each cell line. Data was combined for the plot, and error bars showed with SD from the
mean.antigen presentation. As expected, the introduction of CRT into K42
(CRT−/−) cells restored the efﬁcient processing and presentation of
endogenous class I antigen presentation, comparable to the level
achieved by the OVA expressing EG7 cell line. Collectively, these data
suggest that CRT fragments in CRT deﬁcient cells have a profoundly
negative effect on endogenous antigen processing and presentation.
3. Discussion
There are several possible mechanisms by which truncated CRT
could affect the loading of MHC class I molecules with high afﬁnity
peptide. Firstly, poor peptide supply in the ER, due to dysfunction of
TAP or TAP protein folding, or impaired assembly in truncated CRT
transfected K42 (CRT−/−) cells. However, our western blot and
peptide transport assays do not support this, since the truncated CRT
transfected K42 (CRT−/−) cells were shown to have the same level
of TAP protein expression (Fig. 3a) and peptide translocation ability
seen in the parental K42 (CRT−/−) cells (Fig. 4). Secondly, the
presence of truncated CRT in K42 (CRT−/−) cells may affect the
content of other chaperones in the MHC class I PLC, such as calnexin,
tapasin and ERp57. In our experiments this was proved not to be the
case either, since similar protein expression levels of these chaperones
in truncated CRT transfected K42 (CRT−/−) cells to that of parental
K42 cells was found by semi-quantitative western blot (Fig. 3a).
Thirdly, impaired ability of PLC to load peptide onto class I molecules
could affect the generation of peptide receptive class I molecules,
leading to reduced surface class I expression.
Empty H-2Kb molecules could be stabilized and expressed at the
cell surface by incubation with saturating Kb binding peptide. The
surface expression of Kb-peptide complexes (stained by Y3) was
inreased in different cell lines when the cells were pulsed with
SIINFEKL peptide. The rank for the increase is as follows: K42-PNK42-
NPNK42-PCNK42NK42-CRT (data not shown). Furthermore, direct
delivery of SIINFEKL using ER leader/SIINFEKL vaccinia recombinant
into the ER in a TAP-independent manner rescued the ability of K42-P,
K42-PC and K42-NP to present epitopes at the cell surface (data not
shown). It still cannot be excluded that the peptide optimisation process
is impaired in these cells as the concentration of peptide expressed by
vaccinia viruses is high, which could compensate for the defect in peptide
loading [26]. Nevertheless, it seems that CRT deﬁcient cells do not have a
global defect in intracellular peptide loading of peptide.
To ﬁnd out whether endogenous antigen presentation in the
transfectants was impaired, the model antigen ovalbumin was delivered
into the cytoplasm by streptolysin O, and B3Z responses were used to
quantify the relative amount of surface SIINFEKL/Kb complex [22,23]. Our
results showed that at the same concentrations of cytosolic ovalbumin,
the truncated CRT transfected K42 (CRT−/−) cells presented SIINFEKL/
Kb to B3Z less efﬁciently than the parental K42 (CRT−/−) cells. In
contrast, expression of full length CRT in K42 cells increased the efﬁciency
of presenting SIINFEKL in the context of Kb to T cells (Fig. 6). These data
revealed that the expression of truncated CRT dramatically reduced the
ability of K42 (CRT−/−) cells to present endogenous antigen, while full
length CRT increased the efﬁciency.
Similarly it would be interesting to know whether the expression
of truncated CRT in K42 (CRT−/−) cells affects the formation of the
PLC resulting in the phenotype described above. Co-immunoprecip-
itation experiments were performed to measure the protein–protein
interactions in PLC of K41, K42 and their CRT P domain transfectants
(Fig. 5). Fewer MHC class I molecules were incorporated into the PLC
of K42, K42-P cells comparedwith that of K41 and K41-P cells. Despite
the reduced surface class I expression on K42-P cells however, the
same amount of class I was found in the PLC of K42-P and its parental
K42 cells, suggesting that the presence of the CRT P-domain did not
affect the formation of PLC. Thus, in the absence of CRT, truncated
CRTs, which all contain the central proline rich P domain capable of
interacting with ERp57 and also possessing the lectin site of CRT
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with calnexin for the formation of PLC to block its function and the
function of PLC, leading to the further reduced cell surface expression
of MHC class I. Support for this hypothesis came from the
coimmunoprecipitation results of K41 and K41-P. Less CRT proteins
were incorporated into the PLC of K41-P compared with that of K41,
which indicated that the expression of the CRT P-domain 14 in CRT
competent K41 cells led to decreased native CRT recruitment into the
PLC. The effect of P-domain on the formation of the PLC in K41 cells
was not sufﬁcient to affect MHC class I folding, assembly and peptide
loading as judged by the normal cell surface class I expression on
K41-P.
Another possible mechanism bywhich truncated CRT could down-
regulate class I molecules in K42 (CRT−/−) cells is by truncated CRTs
competing with calnexin at an early stage of biogenesis of MHC class I
molecules. As described before, calnexin interacts withMHC class I HC
upon its co-translational insertion in the ER membrane to facilitate
the folding of HC and stabilize it from aggregation as well as promote
its assembly with β2M [28–32]. When the interaction of calnexin with
class I HCs was prevented by treatment with the oligosaccharide
processing inhibitor castanospermine, the HCs underwent a rapid
degradation compared with the control cells [33]. Moreover,
Vassilakos et al. have demonstrated that in the absence of calnexin
interaction, the assembly of class I heavy chain (HC) and β2M was
substantially impaired due to misfolding of the HCs [32]. Transfected
CRT fragments, containing the central P-domain with the lectin
binding site, could bind the glycan moieties on class I HC preventing
HC interaction with calnexin, which could result in the accelerated
intracellular degradation of the HCs without the chaperone function
of calnexin. Indeed, our semiquantitative western blot result showed
that the steady-state protein expression level of HCs in truncated CRT
transfected K42 cells was lower than that in its parental K42 cells
(Fig. 3a), indicating that the P-domain of CRT may compete with
calnexin for binding to free class I HCs to block its function of
facilitating the folding of HCs. In this way, the P-domain of CRT may
further reduce cell surface class I expression on K42 cells.
Calreticulin might act as a bridge to link other functional compo-
nents of class I assembly machinery. One domain of calreticulin may
be required for interaction with a functional molecule while the other
executes another unidentiﬁed function. ERp57 could be one such
interaction partner in this regard. There are several reports suggesting
that the P-domain of calreticulin is responsible for binding to ERp57,
which is capable of interacting with the conserved cysteines in the
peptide-groove of MHC class I molecules [34,35]. Thus in combination
with ERp57 and PDI, calreticulin, and in particular its P-domain,
appears to play a critical role in the process of MHC class I antigen
processing and presentation.4. Materials and methods
4.1. Cells, peptides and antibodies
Wild-type C57/B6 ﬁbroblast cell line K41 and its CRT deﬁcient
counterpart K42 were kindly provided by Dr M. Michalak [36,37].
Antibodies 9E10 (anti-human c-myc), BBM1 (anti-human β2-micro-
globulin) and Y3 (anti-H-2Kb) were obtained from the ATCC. B3Z was
a gift from Dr N. Shastri. EG7 was provided by Alain Townsend. The
cell lines were grown in RPMI 1640 supplementedwith 10% FCS and L-
glutamine (Gibco BRL). Anti-human CRT antibodies were purchased
from Stressgen and described before [9]. Rabbit serum against murine
tapasin and TAP were kindly provided by Ping Wang. Ovalbumin
peptides 257–284 (SIINFEKL), a H-2Kb binding peptide, ﬂu peptide
(GILGFVFTL), a HLA-A2 associated peptide and ﬂuorescently labelled
RRYQNSTEL (HLA-B27 binding peptide) were purchased from Euro-
gentic (Belgium). All other reagents were purchased from Sigma.4.2. CRT and its fragment constructs
Different CRT domains were ampliﬁed using PCR. The following
primers were synthesized by Sigma: Forward-F 5′-(PstI)CTG CAG-gag
cct gcc gtc tac ttc aag-3′; Reverse-F 5′-(NotI)GC GGC CGC-ggc ctg gcc
ggg gac atc ttc-3′; Reverse-NP 5′-(Not I)GC GGC CGC-ata ggc ata gat
act ggg atc-3′ and Forward-P 5′-(PstI)CTG CAG-gat tgg gac ttc ctg cca
ccc-3′. The full length of CRT (AA1–AA400) omitting the original ER
retention signal was ampliﬁed with primer pair Forward-F and
Reverse-F; CRT-P (AA180–AA280) domain with Forward-P; CRT-NP
(AA1–AA280) domain with Forward-F and Reverse-NP and CRT-PC
(AA180–AA400) domain with Forward-P respectively. Taq DNA Poly-
merase (Invitrogen) was used. The reagents were mixed in a total
volume of 50 µl and PCR reactions were carried out for 30 cycles on a
GeneAmp PCR System 9700 (PE Applied Biosystems) with the
following conditions: 1, 94 °C 45 s; 2, 55 °C 45 s; 3, 72 °C 60 s and 4,
72 °C 10 min. The PCR products were gel puriﬁed and digested and
then inserted between ER leader signal and myc tag followed by
SEKEDL retention signal on the vector pEF/myc/ER (Invitrogen). The
ﬁnal constructs were sequence veriﬁed.
4.3. Stable cell lines expressing different CRT constructs
Both K41 and K42 were transfected with pEF/myc/ER constructs
with human full length of CRT omitting original ER retrieve signal, P-
domain (amino acids 180–280), PC (amino acids 180–400) and NP-
domain (amino acids 1–280) inserted between ER leader sequence
and myc tag followed by SEKDEL ER retention signal. The transfection
was done using Lipofectamine kit provided by Invitrogen according to
the manufacturer's instruction. The stable cell lines were selected
with 6 mg/ml G418 (SIGMA) and cloned by limited dilution.
4.4. Immunoﬂuorescence staining
The cells were seeded at a density of 1×105 cells/plate in a 60 mm
plates containing sterile glass coverslips and cultured for 24 h. The
cells on coverslips were rinsed with PBS and ﬁxed on ice with PBS
containing 4% paraformaldehyde for 15 min, and then the cells were
permeabilized with 0.5% Triton-X100 in PBS for 15 min on ice. After
washing with PBS and incubation for 30 min at room temperature
with PBS containing 2.5% BSA, the slips were stainedwith a mixture of
mouse monoclonal anti-myc antibody (1:400) and rabbit polyclonal
anti-calnexin antibody (1:500) in PBS containing 2.5% BSA for K42 cell
and transfectant cell lines, and incubated with rabbit polyclonal anti-
CRT antibody in PBS containing 2.5% BSA for K41 cells. After washing
with PBS, the cells were incubated with a mixture of rhodamine-
labelled goat anti-rabbit IgG (1:400, Santa Cruz) and FITC-labelled
goat anti-mouse IgG (1:400, Santa Cruz) in PBS containing 2.5% BSA
for K42 cell and transfectant cell lines, and incubatedwith rhodamine-
labelled goat anti-rabbit IgG (1:400, Santa Cruz) in PBS containing
2.5% BSA for K41 cell. Fluorescently labelled cells were washed three
times with PBS and then mounted on slide glass with 90% glycerol.
Samples were analysed by using a ﬂuorescence confocal microscopy
(Leica TCS SP2).
4.5. Immunoblotting
1×106 exponentially growing cells were lysed on ice in 1 ml Tris
buffered saline (TBS, pH 7.4) containing 0.5% Nonidet P-40, 0.5 mM
PMSF (Sigma) and 2 mg/ml IAA (Sigma). The lysates were resolved by
12% SDS-PAGE and transferred onto Hybond Extra-C membrane
(Amersham). After blocking with 2.5% skimmed milk (Marvel) in
phosphate buffered saline (PBS, pH 7.4), the membrane was
incubated with antibody in PBS containing 0.05% Tween 20 (PBST,
pH 7.4) containing 2.5% skimmed milk (Marvel) for 1 h at room
temperature. The membrane was washed with PBST twice and
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(Sigma) in PBS with 2.5% skimmed milk. The membrane was
thoroughly washed three times with PBST and visualised with an
enhanced chemiluminescence detection system according to the
manufacturer's instructions (Pierce). The treatment of cells with
proteasome inhibitors was used to analyse whether HC steady state
levels can be rescued in transfectant cell lines. A mixture of MG-115
(Alexis, USA) and MG-132 (Alexis, USA) diluted in DMSO were added
to cell cultures both at a ﬁnal concentration of 5 μM for 6 h, whereas
control plates were treated with the same amount of DMSO. Treated
cells were collected and lysed on ice in 1 ml Tris buffered saline (TBS,
pH 7.4) containing 0.5% Nonidet P-40 in the presence of a cocktail of
proteinase inhibitors. The lysates were resolved by 15% SDS-PAGE and
analysed by immunoblotting. Software Quantity One 4.6.2 (Bio-RAD)
was used to analyse the scanned blot quantitatively.
4.6. Co-immunoprecipitation
1.5×107 cells were lysed in digitonin (Wako) lysis buffer (1%
digitonin, 150 mM NaCl, 10 mM Tris pH 7.6, 1 mM PMSF, 10 mM N-
ethylmaleimide) on ice for 15 min. Lysates were spun at 14,000 rpm to
remove insoluble debris, and preclearedwith 50 μl Protein G-Sepharose
beads for 30 min. Lysates were then immunoprecipitated with sheep
anti-rat TAP1 and TAP2 sera (which also recognises mouse TAP), or
monoclonal anti-Kb antibody, and Protein G-Sepharose beads. Beads
were washed 3 times in lysis buffer and heated in non-reducing sample
buffer. Samples were run on 8% SDS-PAGE, immunoblotted and probed
with relevant antibodies.
4.7. Flow cytometry analysis
Cells were harvested and re-suspended to a concentration of 106
cells/ml in cold FACS buffer (1×PBS, 1% fetal calf serum, and 0.1%
sodium azide) and 100 μl aliquots were added to wells in a round-
bottom 96-well plate (Merck). The plate was centrifuged at 300×g for
5 min, the supernatant ﬂicked off gently and the plate vortexed to lose
the cells. The appropriate antibody in 50 μl of FACS buffer was added
to the wells and incubated in the dark at 4 °C for 30 min. If required
cells were further stained with the secondary antibody as above and
ﬁxed (2% Paraformaldehyde in PBS, pH 7.4) and analysis was carried
out on a Becton Dickinson FACScan running CellQuest software.
Typically 20,000–50,000 events were collected for eachmeasurement.
4.8. Antigen presentation assay with B3Z
1×106 cells were washed twice with warm RPMI 1640, resus-
pended in 200 μl RPMI 1640 in a 24-well plate. The cells were
permeabilized by adding Streptolysin-O (SLO, SIGMA) (10 U/106 cells
for K41, K42 and K42-CRT; 45 U/106 cells for RMA and RMA-S) to the
wells. Ovalbumin or BSA as control were added and incubated at 37 °C
with 5% CO2 for 10 min. 500 μl of media with 10% FCS was added and
incubated for further 30 min. The cells were resuspended at 1×106/ml.
100 μl of cell were cultured with 100 μl of 1×106/ml B3Z cells over-
night. The cells were washed once with 200 μl PBS and lysed by
addition of 100 μl Z buffer (0.12 mM Chlorophenolred-beta-D-galacto-
pyranoside (CPRG, Calbiochem), 100 mM 2-mercaptoethanol, 9 mM
MgCl2, 0.125% NP-40 in PBS). After 4 h of incubation at 37 °C, 50 μl stop
buffer (300 mM glycine and 15 mM EDTA in water) was added and the
signal was read in an ELISA reader at 570 nm referenced at 630 nm [26].
4.9. Peptide transport assay
3×106 cells were washed twice with RPMI 1640 media and
permeabilized for 10 min at 37 °C with streptolysin-O described as
above. Cells were then washed once with MgCl2 buffer (0.005 MMgCl2
in PBS) and resuspended in 200 μl warm translocation buffer (78 mMKCl, 4 mMMgCl2, 8.4 mM CaCl2, 10 mM EGTA, 1 mM DTT, 10 mM ATP,
0.1%BSA, 50 mM HEPES, PH7.0). Fluorescein (FITC) tagged RRYQNSTEL
peptide [35]was added to the cells at a ﬁnal concentration of 10 μMand
the cells were incubated at 37 °C for 10 min. 1 ml ice-cold lysis buffer
(1%NP-40 in PBS) was added followed by incubation on ice for 15 min.
Insoluble proteins were removed by centrifugation at 20,000×g for
15 min and glycosylated peptides were bound to 50 μl concanavalin A
Sepharose beads (50%) by overnight incubation at 4 °C with vigorous
agitation. The beads were washed three times with 0.1% NP-40 in PBS
and then bound peptides were eluted by a 60 min vigorous agitation in
500 μl of 200 mmol/l methyl-α-D-mannopyranoside in PBS, in the dark
at room temperature. The ﬂuorescence intensity of supernatants was
quantiﬁed using a ﬂuorescence spectrometer with excitation and emis-
sion wavelengths at 484 nm and 535 nm, respectively. The readingwas
calculated as the proportion of the total ﬂuorescent peptide added that
was transported into the ER.
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